Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L2ZY
|
|||
Former ID |
DNCL002239
|
|||
Drug Name |
X-82
|
|||
Indication | Age-related macular degeneration [ICD-11: 9B75.0; ICD-10: H35] | Phase 2 | [1] | |
Macular degeneration [ICD-11: 9B78.3; ICD-10: H35.3] | Phase 1 | [2] | ||
Solid tumour/cancer [ICD-11: 2A00-2F9Z] | Phase 1 | [2] | ||
Company |
Tyrogenex West Palm Beach
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Platelet-derived growth factor receptor (PDGFR) | Target Info | Modulator | [3] |
Vascular endothelial growth factor receptor (VEGFR) | Target Info | Inhibitor | [4] | |
Vascular endothelial growth factor receptor 1 (FLT-1) | Target Info | Modulator | [3] | |
KEGG Pathway | Ras signaling pathway | |||
Rap1 signaling pathway | ||||
Cytokine-cytokine receptor interaction | ||||
HIF-1 signaling pathway | ||||
Endocytosis | ||||
PI3K-Akt signaling pathway | ||||
Focal adhesion | ||||
Transcriptional misregulation in cancer | ||||
Rheumatoid arthritis | ||||
Pathway Interaction Database | Glypican 1 network | |||
HIF-2-alpha transcription factor network | ||||
S1P3 pathway | ||||
VEGF and VEGFR signaling network | ||||
VEGFR1 specific signals | ||||
Signaling events mediated by VEGFR1 and VEGFR2 | ||||
Reactome | Neurophilin interactions with VEGF and VEGFR | |||
VEGF binds to VEGFR leading to receptor dimerization | ||||
WikiPathways | Focal Adhesion | |||
Signaling by VEGF | ||||
Angiogenesis |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02348359) X-82 to Treat Age-related Macular Degeneration. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Tyrogenex. | |||
REF 3 | National Cancer Institute Drug Dictionary (drug id 695817). | |||
REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.